Compounds > fingolimod hydrochloride
Page last updated: 2024-09-02

fingolimod hydrochloride and Pancreatic Neoplasms

fingolimod hydrochloride has been researched along with Pancreatic Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's4 (66.67)2.80

Authors

AuthorsStudies
Hiramoto, M; Hirota, A; Kazama, H; Miyazaki, M; Miyazawa, K; Ogawa, M; Ota, K; Suzuki, S; Takano, N1
Baek, DJ; Cho, SW; Kim, KJ; Kim, SB; Oh, YS; Park, EY; Park, SK1
Aoki, H; Aoki, M; Hylemon, P; Sarkar, J; Takabe, K; Wu, R; Zhou, H1
Abdel-Salam, MML; Ahmad, SA; Bachmann, M; Becker, KA; Carpinteiro, A; Gulbins, E; Kadow, S; Keitsch, S; Patel, SH; Soddemann, M; Szabo, I; Wilker, B; Wilson, GC; Xu, K1
Cai, M; Shen, Y; Wang, C; Wang, X; Xia, W; Xie, H; Zheng, S; Zhou, L1
Cai, M; Liu, J; Shen, Y; Wang, C; Wang, X; Xia, W; Xie, H; Zhang, Q; Zheng, S1

Other Studies

6 other study(ies) available for fingolimod hydrochloride and Pancreatic Neoplasms

ArticleYear
Lysosome‑targeted drug combination induces multiple organelle dysfunctions and non‑canonical death in pancreatic cancer cells.
    Oncology reports, 2022, Volume: 47, Issue:2

    Topics: Aminopyridines; Antineoplastic Agents; Benzimidazoles; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Drug Synergism; Endoplasmic Reticulum Stress; Fingolimod Hydrochloride; Humans; Hydroxychloroquine; Lapatinib; Lysosomes; Pancreatic Neoplasms; Sphingosine 1 Phosphate Receptor Modulators

2022
Synthesis of PP2A-Activating PF-543 Derivatives and Investigation of Their Inhibitory Effects on Pancreatic Cancer Cells.
    Molecules (Basel, Switzerland), 2022, May-23, Volume: 27, Issue:10

    Topics: Fingolimod Hydrochloride; Humans; Methanol; Molecular Docking Simulation; Pancreatic Neoplasms; Protein Phosphatase 2; Pyrrolidines; Sulfones

2022
Conjugated Bile Acids Accelerate Progression of Pancreatic Cancer Metastasis via S1PR2 Signaling in Cholestasis.
    Annals of surgical oncology, 2023, Volume: 30, Issue:3

    Topics: Animals; Bile Acids and Salts; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholestasis; Fingolimod Hydrochloride; Humans; Liver Neoplasms; Mice; Pancreatic Neoplasms; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; Steroids

2023
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivo.
    Journal of molecular medicine (Berlin, Germany), 2023, Volume: 101, Issue:3

    Topics: Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Fingolimod Hydrochloride; Humans; Lysosomes; Mitochondria; Pancreatic Ducts; Pancreatic Neoplasms; Sphingomyelin Phosphodiesterase; Sphingomyelins

2023
Antiproliferative and overadditive effects of rapamycin and FTY720 in pancreatic cancer cells in vitro.
    Transplantation proceedings, 2008, Volume: 40, Issue:5

    Topics: Cell Division; Cell Line, Tumor; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Pancreatic Neoplasms; Propylene Glycols; Sirolimus; Sphingosine

2008
FTY720, a synthetic compound from Isaria sinclairii, inhibits proliferation and induces apoptosis in pancreatic cancer cells.
    Cancer letters, 2007, Sep-08, Volume: 254, Issue:2

    Topics: Adenocarcinoma; Apoptosis; Ascomycota; Cell Division; Cell Line, Tumor; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Pancreatic Neoplasms; Propylene Glycols; Sphingosine; Wound Healing

2007